This integrative strategy not only provides robust genetic evidence supporting a causal role for TL in ccRCC susceptibility but also elucidates novel mechanisms through telomerase-associated genes (such as NOP10 and NHP2). The gene discussed is NOP10; the disease is nonpapillary renal cell carcinoma.